Close Menu

Nazneen Rahman has figured out a way to make genetic testing more easily accessible for UK women with ovarian cancer, writes Ed Yong at the Atlantic. Women with BRCA1 or BRCA2 mutations are more likely to respond to certain chemotherapy drugs and PARP inhibitors, but getting tested can be difficult.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.